FDA NDC Directory · JSON-LD · Markdown

fluticasone propionate and salmeterol

NDC 0054-0327 · HUMAN PRESCRIPTION DRUG · POWDER

Labeler / ManufacturerHikma Pharmaceuticals USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203433
Dosage form / routePOWDER · RESPIRATORY (INHALATION)
Active ingredientsFLUTICASONE PROPIONATE (250 ug/1)
SALMETEROL XINAFOATE (50 ug/1)
Marketing started20201217
Package count1

External sources

Source: openFDA. Public-domain (CC0).